Cefaclor
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-00706 |
| CAS | 53994-73-3 |
| Molecular Weight | 367.81 |
| Molecular Formula | C15H14ClN3O4S |
| Purity | >98% |
Online Inquiry
Description
It is produced by the strain of Semisynthetic second generation oral cephalosporin. It is used to treat some infections caused by bacteria such as pneumonia.
Specification
| Related CAS | 70356-03-5 (hydrate) |
| Synonyms | Cephaclor; Ceclor; Cefaclorum; Kefral; Panoral; Raniclor; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid |
| IUPAC Name | (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Canonical SMILES | C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl |
| InChI | InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1 |
| InChI Key | QYIYFLOTGYLRGG-GPCCPHFNSA-N |
Properties
| Appearance | Colorless Crystalline Powder |
| Application | Anti-Bacterial Agents |
| Boiling Point | 713.4±60.0 °C (Predicted) |
| Density | 1.357 g/cm3 (Predicted) |
| Solubility | Soluble in Water; Insoluble in Methanol, Benzene, Chloroform |
Reference Reading
1.Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
Soyletir G1, Altinkanat G1, Gur D2, Altun B2, Tunger A3, Aydemir S3, Kayacan C4, Aktas Z4, Gunaydin M5, Karadag A5, Gorur H6, Morrissey I7, Torumkuney D8. J Antimicrob Chemother. 2016 May;71 Suppl 1:i71-i83. doi: 10.1093/jac/dkw075.
OBJECTIVES: Data are presented from the Survey of Antibiotic Resistance (SOAR) for respiratory tract infection pathogens collected in 2011-13 from Turkey.
2.A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea.
Yoldaş Ö1, Altındiş M2, Cufalı D3, Aşık G3, Keşli R3. Balkan Med J. 2016 Jan;33(1):80-6. doi: 10.5152/balkanmedj.2015.15159. Epub 2016 Jan 1.
BACKGROUND: Clostridium difficile is a common cause of hospital-acquired diarrhea, which is usually associated with previous antibiotic use. The clinical manifestations of C. difficile infection (CDI) may range from mild diarrhea to fulminant colitis. Clostridium difficile should be considered in diarrhea cases with a history of antibiotic use within the last 8 weeks (community-associated CDI) or with a hospital stay of at least 3 days, regardless of the duration of antibiotic use (hospital-acquired CDI).
3.Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.
Jamsheer A1, Rafay AM2, Daoud Z3, Morrissey I4, Torumkuney D5. J Antimicrob Chemother. 2016 May;71 Suppl 1:i45-i61. doi: 10.1093/jac/dkw064.
OBJECTIVES: To provide surveillance data on the susceptibility of community-acquired respiratory tract isolates from four Gulf and Near East countries from 2011 to 2013.
4.Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
Van PH1, Binh PT1, Minh NH2, Morrissey I3, Torumkuney D4. J Antimicrob Chemother. 2016 May;71 Suppl 1:i93-i102. doi: 10.1093/jac/dkw069.
OBJECTIVES: To investigate the susceptibility of respiratory tract infection pathogens collected between 2009 and 2011 from the SOAR study in Vietnam.
Recommended Products
| BBF-02614 | Nystatin | Inquiry |
| BBF-00677 | 3-Amino-3-deoxy-D-glucose | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-03753 | Baicalin | Inquiry |
| BBF-02642 | Lactonamycin | Inquiry |
| BBF-03754 | CASTANOSPERMINE | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
